Superior insight in drug safety and efficacy

Washington  •  London  •  Paris

• Drug safety
  • Patient profiles at risk of adverse events
• Clinical development
  • Target population for efficacy
  • Composite endpoint optimization
  • Fraud detection

Key applications - Drug safety

Patient profiles at risk of adverse events

Serious adverse event rate can be clearly very low in the general population. However this rate can reach within certain subgroups of patients, under specific conditions an unexpected high level leading to a poor benefit - risk ratio jeopardizing the legitimacy of the drug on the market.

The identification of such subgroups of patients and conditions allows to precise special warning and possible interactions and sometimes to define contraindications in order to maintain a favorable benefit - risk ratio.